NDC 24208-358
Zylet
Loteprednol Etabonate And Tobramycin
Zylet is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Loteprednol Etabonate; Tobramycin.
| Product ID | 24208-358_0e91d40c-b306-46b0-90b2-bc015f0f86c5 |
| NDC | 24208-358 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zylet |
| Generic Name | Loteprednol Etabonate And Tobramycin |
| Dosage Form | Suspension/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2004-12-14 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050804 |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LOTEPREDNOL ETABONATE; TOBRAMYCIN |
| Active Ingredient Strength | 5 mg/mL; mg/mL |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 24208-358-01
1 BOTTLE, DROPPER in 1 CARTON (24208-358-01) > 1 mL in 1 BOTTLE, DROPPER
| Marketing Start Date | 2004-12-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 24208-358-25 [24208035825]
Zylet SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA050804 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2004-12-14 |
| Marketing End Date | 2013-01-25 |
NDC 24208-358-10 [24208035810]
Zylet SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA050804 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2004-12-14 |
NDC 24208-358-01 [24208035801]
Zylet SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA050804 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2004-12-14 |
NDC 24208-358-05 [24208035805]
Zylet SUSPENSION/ DROPS
| Marketing Category | NDA |
| Application Number | NDA050804 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2004-12-14 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LOTEPREDNOL ETABONATE | 5 mg/mL |
OpenFDA Data
| SPL SET ID: | 3dd9b060-5355-404d-bdf1-09ee8b52a9f5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Corticosteroid [EPC]
- Corticosteroid Hormone Receptor Agonists [MoA]
- Aminoglycoside Antibacterial [EPC]
- Aminoglycosides [CS]
Medicade Reported Pricing
24208035810 ZYLET EYE DROPS
Pricing Unit: ML | Drug Type:
24208035805 ZYLET EYE DROPS
Pricing Unit: ML | Drug Type:
Trademark Results [Zylet]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ZYLET 78112937 3002481 Live/Registered |
BAUSCH & LOMB INCORPORATED 2002-03-06 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.